Last checked at 25 Jun 2021 12:36
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 24 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
7,556,668 | 3.00% | 134,639 | 0.05% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
82,054 | 0.03% | 7,097,263 | 2.82% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
7,638,722 | 3.03% | 7,231,902 | 2.87% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 20 | 10.4500 GBP |
| Purchase | 146 | 10.3900 GBP |
| Purchase | 472 | 10.3972 GBP |
| Purchase | 1,328 | 10.3998 GBP |
| Purchase | 2,033 | 10.3600 GBP |
| Purchase | 2,536 | 10.3679 GBP |
| Purchase | 7,308 | 10.4594 GBP |
| Purchase | 7,353 | 10.4572 GBP |
| Purchase | 9,324 | 10.3695 GBP |
| Purchase | 9,666 | 10.4600 GBP |
| Purchase | 9,703 | 10.3897 GBP |
| Purchase | 9,991 | 10.3774 GBP |
| Purchase | 11,760 | 10.4300 GBP |
| Purchase | 48,110 | 10.3728 GBP |
| Purchase | 85,711 | 10.4141 GBP |
| Purchase | 171,804 | 10.4027 GBP |
| Sale | 133 | 10.3800 GBP |
| Sale | 250 | 10.3807 GBP |
| Sale | 318 | 10.3550 GBP |
| Sale | 512 | 10.3659 GBP |
| Sale | 814 | 10.3678 GBP |
| Sale | 836 | 10.3600 GBP |
| Sale | 1,085 | 10.3700 GBP |
| Sale | 3,194 | 10.3881 GBP |
| Sale | 7,208 | 10.3850 GBP |
| Sale | 7,489 | 10.3744 GBP |
| Sale | 7,668 | 10.3713 GBP |
| Sale | 8,690 | 10.4469 GBP |
| Sale | 8,884 | 10.3673 GBP |
| Sale | 9,374 | 10.3736 GBP |
| Sale | 10,493 | 10.3810 GBP |
| Sale | 14,157 | 10.3783 GBP |
| Sale | 21,288 | 10.3926 GBP |
| Sale | 21,554 | 10.3823 GBP |
| Sale | 23,424 | 10.3828 GBP |
| Sale | 31,965 | 10.4600 GBP |
| Sale | 50,400 | 10.4449 GBP |
| Sale | 99,386 | 10.4170 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
| CFD | Long | 3,194 | 10.3886 GBP |
| SWAP | Long | 3,650 | 10.4600 GBP |
| SWAP | Long | 3,807 | 10.4141 GBP |
| CFD | Long | 6,098 | 10.3445 GBP |
| SWAP | Short | 584 | 10.4078 GBP |
| SWAP | Short | 15,990 | 10.3746 GBP |
| SWAP | Short | 21,466 | 10.3723 GBP |
| SWAP | Short | 38,194 | 10.3869 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 25 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210625005223/en/
Copyright Business Wire 2021